Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 CAD | -5.16% | -9.82% | -56.12% |
14/05 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.12% | 18.49M | |
+64.68% | 62.59B | |
-2.01% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.77% | 26.21B | |
-21.89% | 19.09B | |
+3.69% | 13.08B | |
+25.96% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences : Names Finance, Operations VPs